Jin Ah Jung

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis

Jin Ah Jung, Soo‐Youn Lee, Tae‐Eun Kim et al. · Drug Design Development and Therapy · 2015 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid

Hee Youn Choi, Kyun‐Seop Bae, Sang‐Heon Cho et al. · Pharmacogenetics and Genomics · 2015 · 48 citations

Medicine, Pharmacokinetics, Pharmacology +17

Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family

Md Masud Parvez, Nazia Kaisar, Ho Jung Shin et al. · Antimicrobial Agents and Chemotherapy · 2016 · 33 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake

Md Masud Parvez, Jin Ah Jung, Ho Jung Shin et al. · Antimicrobial Agents and Chemotherapy · 2016 · 29 citations · Full text

Medicine, Pharmaceutics, Pharmacology +13

Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant <i>Staphylococcus aureus</i> by modeling and simulation

Hyun‐Sook Lim, Yong Pil Chong, Yun Hee Noh et al. · Journal of Clinical Pharmacy and Therapeutics · 2014 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +17